Recruiting
Phase 3

Erector Spinae Plane Block vs. Intrathecal Morphine

Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Code:

NCT04256642

Conditions

Cesarean Section Complications

Eligibility Criteria

Sex: Female

Age: 18 - 45

Healthy Volunteers: Accepted

Interventions

Erector Spinae Plane Block

Intrathecal morphine

Study Details

Brief summary:

This study is a Randomized Control Trial comparing the Erector Spinae Plane Block with intrathecal morphine for post cesarean delivery analgesia.

Conditions

Cesarean Section Complications

Study ID

NCT04256642

Start date

Feb, 2020

Status verified date

Feb, 2020

Completion date

Jan, 2023

Anticipated

Primary completion date

Jan, 2022

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18 - 45

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Patients undergoing scheduled Cesarean delivery

Exclusion Criteria:

  • Patients with an ASA score greater than 3
  • Allergies to study medications
  • Contraindications to neuraxial analgesia
  • Patients with chronic pain
  • Patients unable to communicate in the study language

Study Design

Enrollment

160 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

active comparator: Intrathecal morphine

experimental: Erector Spinae Plane Block

Interventions

Erector Spinae Plane Block

A nerve block that injects local anesthetic in the Erector Spinae Plane

Intrathecal morphine

Intrathecal morphine at the time of spinal anesthesia

Primary outcome measure

  • 24 hour area under the curve pain scores [ Time Frame: First 24 hour ]

Central Contacts and Locations

Central contacts

Albert Moore, MD

5149341934albert.moore@mcgill.ca

Locations

Royal Victoria Hospital

Recruiting

Montreal, Quebec, Canada

Contacts

Albert Moore, MD

moore_albert@hotmail.com

More Information

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Last update posted

Feb 5, 2020

Last verified

Feb, 2020

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by McGill University Health Centre/Research Institute of the McGill University Health Centre on 2020-02-05.